Skip to content
SAMVEXA NEWSSAMVEXANEWS
Latest

U.S.

Allarity Granted U.S. Patent for Stenoparib Dosing Methods

Allarity Therapeutics has received a U.S. patent for methods of using its drug candidate Stenoparib to treat ovarian cancer and solid tumors.

1 min read
Photo: NASA Johnson Space Center / Wikimedia Commons (Public domain) · representative image

Allarity Therapeutics Inc. announced on Wednesday that it has been granted a patent by the U.S. Patent and Trademark Office (USPTO).

The patent covers specific treatment regimens involving Stenoparib, the company's lead drug candidate. These methods are intended for the treatment of ovarian cancer and other types of solid tumors.

This information is based on a report by Rttnews.

More stories

Tech
Bengaluru

Bengaluru Developers Contribute to Grand Theft Auto VI

The Indian city of Bengaluru has played a significant role in the development of the highly anticipated video game, Grand Theft Auto VI (GTA 6). Approximately 1,600 developers from the city contributed to the game's creation.